We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Jobs Report Hits 200K, Unemployment 4.1%; Plus More Q4 Earnings
Read MoreHide Full Article
Friday, February 2, 2018
Happy Groundhog Day! As we see on the first Friday of almost every month, new non-farm payrolls from the Bureau of Labor Statistics (BLS) have been released before the opening bell. This comes in conjunction with tonnage of new Q4 earnings reports both after yesterday’s market close and before today’s open. The headline was better than expected, but not a huge surprise: 200K new jobs created in January, with an Unemployment Rate remaining steady at 4.1%.
While this 200K number is higher than the analyst consensus of roughly 180K (analyst for months have been expecting 180K new jobs), it is below the ADP (ADP - Free Report) payroll report released Wednesday morning, which showed 234K new jobs in just the private sector alone. Typically, however, while the ADP and BLS numbers do tend to align with future revisions, initially they are often far apart from one another.
Pre-market trading, which had been deep in the red ahead of the BLS announcement, clawed back to around -180 points on the Dow, only to plummet back to around -225 points following the news. Since that time, in the last 15 minutes or so, markets have again worked to climb out of its early hole. Meanwhile, the 10-year t-bill races up past 2.8% following the release of the jobs data.
Not that there is anything to particularly grieve in today’s jobs report: Construction posted the biggest improvement of any sector compared to a year ago, at 36K new jobs. And the U-6 (aka “real unemployment”) fell to 8.2%, the lowest we’ve seen in quite some time. Otherwise, these figures came in much as expected, aside from the predicted 4.1% unemployment rate, Average Hourly Earnings was again a positive, if tepid, +0.3% (2.9% year over year) and a consistent Labor Force Participation Rate of 62.7%.
Finally, December’s BLS totals were revised upward, from 148K to 160K. This is slightly offset by November’s revision, to 216K from the 252K originally announced.
Q4 Earnings Roundup
Following yesterday afternoon’s modest beat from Apple (AAPL - Free Report) , Amazon’s (AMZN - Free Report) biggest profit in history and Alphabet’s (GOOGL - Free Report) earnings miss on tax adjustment, before today’s bell bring another full load of earnings reports:
ExxonMobil (XOM - Free Report) missed both top- and bottom-line estimates, bringing in 88 cents per share ($1.04 for the Zacks consensus) on $66.5 billion in revenues ($74.4 billion expected). The Zacks Rank #3 (Hold) company has now missed earnings estimates in 2 of the last 5 quarters. For more on XOM’s earnings, click here.
Phillips 66 (PSX - Free Report) , a downstream oil & gas play, easily topped expectations for its quarter: $1.07 per share outpaced the 86 cents anticipated, with $30.12 billion far ahead of the $23.67 billion in the Zacks consensus. For more on PSX’s earnings, click here.
Estee Lauder (EL - Free Report) also surpassed expectations with $1.52 per share and $3.74 billion in revenues beating the $1.44 per share and $3.67 billion we were looking for. The quarter was assisted by double-digit growth in Skincare, Makeup and Fragrance categories. For more on EL’s earnings, click here.
Merck (MRK - Free Report) topped estimates by 4 cents to 98 cents per share, while coming up short on revenue estimates: $10.43 billion as opposed to the $10.49 billion expected. Generic competition has affected the Big Pharma Dow component’s quarter. For more on MRK’s earnings, click here.
And Merck’s competitor AstraZeneca (AZN - Free Report) also faced generic competition for some of its top-selling drugs, but managed to top earnings and revenue expectations: 65 cents per share outperformed by 20 cents, whereas $5.78 billion in sales easily beat the $5.59 billion anticipated. For more on AZN’s earnings, click here.
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Image: Bigstock
Jobs Report Hits 200K, Unemployment 4.1%; Plus More Q4 Earnings
Friday, February 2, 2018
Happy Groundhog Day! As we see on the first Friday of almost every month, new non-farm payrolls from the Bureau of Labor Statistics (BLS) have been released before the opening bell. This comes in conjunction with tonnage of new Q4 earnings reports both after yesterday’s market close and before today’s open. The headline was better than expected, but not a huge surprise: 200K new jobs created in January, with an Unemployment Rate remaining steady at 4.1%.
While this 200K number is higher than the analyst consensus of roughly 180K (analyst for months have been expecting 180K new jobs), it is below the ADP (ADP - Free Report) payroll report released Wednesday morning, which showed 234K new jobs in just the private sector alone. Typically, however, while the ADP and BLS numbers do tend to align with future revisions, initially they are often far apart from one another.
Pre-market trading, which had been deep in the red ahead of the BLS announcement, clawed back to around -180 points on the Dow, only to plummet back to around -225 points following the news. Since that time, in the last 15 minutes or so, markets have again worked to climb out of its early hole. Meanwhile, the 10-year t-bill races up past 2.8% following the release of the jobs data.
Not that there is anything to particularly grieve in today’s jobs report: Construction posted the biggest improvement of any sector compared to a year ago, at 36K new jobs. And the U-6 (aka “real unemployment”) fell to 8.2%, the lowest we’ve seen in quite some time. Otherwise, these figures came in much as expected, aside from the predicted 4.1% unemployment rate, Average Hourly Earnings was again a positive, if tepid, +0.3% (2.9% year over year) and a consistent Labor Force Participation Rate of 62.7%.
Finally, December’s BLS totals were revised upward, from 148K to 160K. This is slightly offset by November’s revision, to 216K from the 252K originally announced.
Q4 Earnings Roundup
Following yesterday afternoon’s modest beat from Apple (AAPL - Free Report) , Amazon’s (AMZN - Free Report) biggest profit in history and Alphabet’s (GOOGL - Free Report) earnings miss on tax adjustment, before today’s bell bring another full load of earnings reports:
ExxonMobil (XOM - Free Report) missed both top- and bottom-line estimates, bringing in 88 cents per share ($1.04 for the Zacks consensus) on $66.5 billion in revenues ($74.4 billion expected). The Zacks Rank #3 (Hold) company has now missed earnings estimates in 2 of the last 5 quarters. For more on XOM’s earnings, click here.
Phillips 66 (PSX - Free Report) , a downstream oil & gas play, easily topped expectations for its quarter: $1.07 per share outpaced the 86 cents anticipated, with $30.12 billion far ahead of the $23.67 billion in the Zacks consensus. For more on PSX’s earnings, click here.
Estee Lauder (EL - Free Report) also surpassed expectations with $1.52 per share and $3.74 billion in revenues beating the $1.44 per share and $3.67 billion we were looking for. The quarter was assisted by double-digit growth in Skincare, Makeup and Fragrance categories. For more on EL’s earnings, click here.
Merck (MRK - Free Report) topped estimates by 4 cents to 98 cents per share, while coming up short on revenue estimates: $10.43 billion as opposed to the $10.49 billion expected. Generic competition has affected the Big Pharma Dow component’s quarter. For more on MRK’s earnings, click here.
And Merck’s competitor AstraZeneca (AZN - Free Report) also faced generic competition for some of its top-selling drugs, but managed to top earnings and revenue expectations: 65 cents per share outperformed by 20 cents, whereas $5.78 billion in sales easily beat the $5.59 billion anticipated. For more on AZN’s earnings, click here.
Mark Vickery
Senior Editor
Questions or comments about this article and/or its author? Click here>>
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Click here for Zacks' private trades >>